1. Home
  2. SQNS vs SCLX Comparison

SQNS vs SCLX Comparison

Compare SQNS & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sequans Communications S.A.

SQNS

Sequans Communications S.A.

HOLD

Current Price

$5.32

Market Cap

85.3M

Sector

Technology

ML Signal

HOLD

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$10.98

Market Cap

90.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SQNS
SCLX
Founded
2003
2011
Country
France
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
85.3M
90.0M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
SQNS
SCLX
Price
$5.32
$10.98
Analyst Decision
Strong Buy
Hold
Analyst Count
3
1
Target Price
$21.33
N/A
AVG Volume (30 Days)
206.8K
77.5K
Earning Date
02-10-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$31,534,000.00
$40,360,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$70.61
$749.70
P/E Ratio
N/A
N/A
Revenue Growth
3.20
N/A
52 Week Low
$4.44
$3.60
52 Week High
$58.30
$34.27

Technical Indicators

Market Signals
Indicator
SQNS
SCLX
Relative Strength Index (RSI) 49.60 35.63
Support Level $5.13 $10.35
Resistance Level $5.50 $13.83
Average True Range (ATR) 0.27 0.94
MACD 0.07 0.01
Stochastic Oscillator 48.55 25.24

Price Performance

Historical Comparison
SQNS
SCLX

About SQNS Sequans Communications S.A.

Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: